v3.26.1
ORGANIZATION AND BASIS OF PRESENTATION (Tables)
12 Months Ended
Dec. 31, 2025
ORGANIZATION AND BASIS OF PRESENTATION  
Summary of principal subsidiaries

As of December 31, 2025, the Company’s principal subsidiaries are as follows:

Percentage of legal

Date of

Place of

ownership

Entity

  ​ ​ ​

incorporation

  ​ ​ ​

incorporation

  ​ ​ ​

by the Company

  ​ ​ ​

Principal activities

Adagene (Hong Kong) Limited

December 12, 2011

 

Hong Kong

 

100

%

Investment holding, and research and development of innovative medicines

Adagene Incorporated

September 20, 2017

 

The United States of America

 

100

%

Research and development of innovative medicines

Adagene (Suzhou) Limited

February 28, 2012

 

The People’s Republic of China (“PRC” or “China”)

 

100

%

Research and development of innovative medicines

Adagene Australia PTY Ltd.

May 30, 2018

Australia

100

%

Research and development of innovative medicines

Adagene PTE. Ltd.

March 27, 2020

Singapore

100

%

Research and development of innovative medicines

Adagene AG

August 31, 2020

 

Switzerland

 

100

%

Research and development of innovative medicines

Adagene Project C1 PTE. Ltd.

March 25, 2022

 

Singapore

 

100

%

Research and development of innovative medicines